forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Weight Loss Drug Market Size, Share GLP-1 Market Size to Hit

Different compounding facilities may use different buffers, different pH levels, different preservative systems, and different concentrations

The future research directions in this field are guided by the need to address the gaps in current knowledge, improve patient care, and optimize the therapeutic benefits of semaglutide while minimizing adverse effects

Clinical studies have shown that individuals using semaglutide experience a significant average weight loss of 14.9% within a year, with about one-third achieving an even more remarkable weight reduction exceeding 20% (PubMed)

Consult with a licensed provider via telehealth